Dr. Kanavy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 E 210th St
Bronx, NY 10467Phone+1 866-633-8255Fax+1 718-944-0870
Summary
- Holly Kanavy, DO, is a dermatologist located in Bronx, NY, and serves as an Associate Professor at Montefiore Medical Center since 2014. She completed her dermatology residency at St Barnabas Hospital in 2014 and graduated from NYIT College Of Osteopathic Medicine in 2007. Her expertise encompasses conditions such as hair loss, atopic dermatitis, psoriasis, melanoma, and acne. Dr. Kanavy has contributed to numerous publications, notably her article on ultraviolet radiation and melanoma, cited over 100 times, and various other studies on dermatological issues. Additionally, she serves as the Director of Dermatopharmacology at Montefiore Medical Center and has been the principal investigator of over 30 clinical trials.
Education & Training
St Barnabas HospitalResidency, Dermatology, 2011 - 2014
NYIT College Of Osteopathic MedicineClass of 2007
Certifications & Licensure
NY State License 2008 - 2027
OH State License 2010 - 2011- AOA Board of Dermatology Dermatology
Clinical Trials
- Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis Start of enrollment: 2020 Jan 15
Publications & Presentations
PubMed
- Hand-foot skin-like reaction associated with tacrolimus therapy in a kidney transplant patient.Anna Chen, Thomas Stringer, Maria Ajaimy, Holly Kanavy
Clinical Transplantation. 2022-07-01 - 11 citationsUltra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells.Kai Wang, Anthony K. Guzman, Zi Yan, Shouping Zhang, Michael Y. Hu
Cell Reports. 2019-03-05 - 31 citationsAcral melanocytic lesions in the United States: Prevalence, awareness, and dermoscopic patterns in skin-of-color and non-Hispanic white patientsReshmi Madankumar, Priyanka Gumaste, Kathryn J. Martires, Panta Rouhani Schaffer, Sonal Choudhary
Journal of the American Academy of Dermatology. 2016-04-01
Press Mentions
Lebrikizumab Safe, Effective Against Moderate-to-Severe Eczema in Mid-Stage TrialMarch 10th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
